Today: 7 February 2026
Subscribe
Browse Category

NZX:FPH News 16 November 2025 - 6 January 2026

New Zealand Stock Market Ends Higher as BlueScope Bid Sparks Steel Rally, Infratil Gains

New Zealand Stock Market Ends Higher as BlueScope Bid Sparks Steel Rally, Infratil Gains

New Zealand’s S&P/NZX 50 index rose 0.56% to 13,663.58 Tuesday, led by steel and construction stocks after a takeover bid for Australia’s BlueScope Steel. Vulcan Steel jumped 3.6%, Steel & Tube 4.7%, and Fletcher Building 1.6%. BlueScope surged 21% in Sydney after receiving a buyout proposal from SGH and Steel Dynamics. Banks fell, with Westpac and ANZ both down 2.6%.
6 January 2026
·········
New Zealand Stock Market Outlook for 4 December 2025: 10 Things to Know Before the NZX Opens

New Zealand Stock Market Outlook for 4 December 2025: 10 Things to Know Before the NZX Opens

The New Zealand sharemarket heads into Thursday’s open on the back of a two‑day rally, a fresh Fonterra update, and growing optimism that global central banks are done with aggressive tightening. Here’s a detailed look at what’s likely to shape trading on Thursday, 4 December 2025. Quick snapshot before the bell Below, we unpack the moving parts. 1. How the NZX closed on Wednesday Wednesday’s session on 3 December 2025 set a constructive tone: Key movers: In short, the market is entering Thursday with positive momentum, powered by heavyweights and yield names rather than speculative microcaps. 2. Overnight global leads:
3 December 2025
······
New Zealand Sharemarket Today: NZX 50 Slides 0.5% as Infratil Sell‑Off Caps Mainfreight Rally (13 November 2025)

New Zealand Sharemarket Today (17 November 2025): Black Pearl Returns, Comvita Deal Collapses, Warehouse Cost Reset in Focus

New Zealand’s stock market heads into Monday’s session under a cloud of caution after a sharp end‑of‑week sell‑off and a flurry of corporate announcements that could drive stock‑specific volatility through the day. On Friday, the S&P/NZX 50 Index fell 133.41 points, or 0.98%, to close at 13,464.46, with 106 decliners and just 34 gainers, as local investors followed Wall Street’s worst day in a month.Good Returns+1 Heavyweights such as Mainfreight, Infratil, Fisher & Paykel Healthcare and Meridian all eased, while smaller cap Comvita slumped after uncertainty over its takeover deal.Good Returns As of early Monday, the NZX Main Board is
16 November 2025
·······

Stock Market Today

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

XRP price today slips near $1.42 as thin weekend liquidity keeps traders on edge

7 February 2026
XRP fell about 5% Saturday to $1.42, extending a 22% weekly drop as thin liquidity and macro jitters drove sharp swings. Bitcoin rebounded above $70,000 after a brief plunge, while ether surged 12%. Ripple outlined plans for an “Institutional DeFi” roadmap, including a new lending protocol and permissioned DEX. The Federal Reserve held rates steady last week, with officials signaling caution on inflation.
Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

Home Depot stock price: jobs, inflation and a Feb. 24 earnings test loom

7 February 2026
Home Depot shares rose 0.7% to $385.15 Friday, trading between $379.10 and $386.37. Investors await a delayed U.S. jobs report Wednesday and CPI data Friday, both postponed by a brief government shutdown. Home Depot reports fourth-quarter earnings Feb. 24. The Dow closed above 50,000 for the first time.
JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

JPMorgan stock price jumps 4% into weekend as Wall Street braces for a busy data week

7 February 2026
JPMorgan shares rose 3.95% to $322.40 Friday, outpacing other major banks as U.S. stocks rallied and the Dow closed above 50,000 for the first time. The bank recently completed a $3 billion subordinated notes offering. Investors are watching for delayed U.S. jobs data and inflation figures next week, ahead of JPMorgan’s Feb. 23 company update.
AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

AbbVie stock price: ABBV ends week near $223 after earnings swing — what to watch next

7 February 2026
AbbVie shares rose 2% to $223.43 Friday, capping a volatile week marked by earnings and drug sales scrutiny. Moody’s upgraded AbbVie’s credit rating to A2, citing strong performance in immunology and neuroscience. Investors remain focused on Skyrizi and Rinvoq growth amid rising competition and recent regulatory filings. Trading volume stayed below average, with the stock still 9% off its 52-week high.
Go toTop